Cargando…

The Removal of Endo- and Enterotoxins From Bacteriophage Preparations

The production of phages for therapeutic purposes demands fast, efficient and scalable purification procedures. Phage lysates have a wide range of impurities, of which endotoxins of gram-negative bacteria and protein toxins produced by many pathogenic bacterial species are harmful to humans. The hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Hietala, Ville, Horsma-Heikkinen, Jenni, Carron, Annelie, Skurnik, Mikael, Kiljunen, Saija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664067/
https://www.ncbi.nlm.nih.gov/pubmed/31396188
http://dx.doi.org/10.3389/fmicb.2019.01674
_version_ 1783439829927723008
author Hietala, Ville
Horsma-Heikkinen, Jenni
Carron, Annelie
Skurnik, Mikael
Kiljunen, Saija
author_facet Hietala, Ville
Horsma-Heikkinen, Jenni
Carron, Annelie
Skurnik, Mikael
Kiljunen, Saija
author_sort Hietala, Ville
collection PubMed
description The production of phages for therapeutic purposes demands fast, efficient and scalable purification procedures. Phage lysates have a wide range of impurities, of which endotoxins of gram-negative bacteria and protein toxins produced by many pathogenic bacterial species are harmful to humans. The highest allowed endotoxin concentration for parenterally applied medicines is 5 EU/kg/h. The aim of this study was to evaluate the feasibility of different purification methods in endotoxin and protein toxin removal in the production of phage preparations for clinical use. In the purification assays, we utilized three phages: Escherichia phage vB_EcoM_fHoEco02, Acinetobacter phage vB_ApiM_fHyAci03, and Staphylococcus phage vB_SauM_fRuSau02. The purification methods tested in the study were precipitation with polyethylene glycol, ultracentrifugation, ultrafiltration, anion exchange chromatography, octanol extraction, two different endotoxin removal columns, and different combinations thereof. The efficiency of the applied purification protocols was evaluated by measuring phage titer and either endotoxins or staphylococcal enterotoxins A and C (SEA and SEC, respectively) from samples taken from different purification steps. The most efficient procedure in endotoxin removal was the combination of ultrafiltration and EndoTrap HD affinity column, which was able to reduce the endotoxin-to-phage ratio of vB_EcoM_fHoEco02 lysate from 3.5 × 10(4) Endotoxin Units (EU)/10(9) plaque forming units (PFU) to 0.09 EU/10(9) PFU. The combination of ultrafiltration and anion exchange chromatography resulted in ratio 96 EU/10(9) PFU, and the addition of octanol extraction step into this procedure still reduced this ratio threefold. The other methods tested either resulted to less efficient endotoxin removal or required the use of harmful chemicals that should be avoided when producing phage preparations for medical use. Ultrafiltration with 100,000 MWCO efficiently removed enterotoxins from vB_SauM_fRuSau02 lysate (from 1.3 to 0.06 ng SEA/10(9) PFU), and anion exchange chromatography reduced the enterotoxin concentration below 0.25 ng/ml, the detection limit of the assay.
format Online
Article
Text
id pubmed-6664067
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66640672019-08-08 The Removal of Endo- and Enterotoxins From Bacteriophage Preparations Hietala, Ville Horsma-Heikkinen, Jenni Carron, Annelie Skurnik, Mikael Kiljunen, Saija Front Microbiol Microbiology The production of phages for therapeutic purposes demands fast, efficient and scalable purification procedures. Phage lysates have a wide range of impurities, of which endotoxins of gram-negative bacteria and protein toxins produced by many pathogenic bacterial species are harmful to humans. The highest allowed endotoxin concentration for parenterally applied medicines is 5 EU/kg/h. The aim of this study was to evaluate the feasibility of different purification methods in endotoxin and protein toxin removal in the production of phage preparations for clinical use. In the purification assays, we utilized three phages: Escherichia phage vB_EcoM_fHoEco02, Acinetobacter phage vB_ApiM_fHyAci03, and Staphylococcus phage vB_SauM_fRuSau02. The purification methods tested in the study were precipitation with polyethylene glycol, ultracentrifugation, ultrafiltration, anion exchange chromatography, octanol extraction, two different endotoxin removal columns, and different combinations thereof. The efficiency of the applied purification protocols was evaluated by measuring phage titer and either endotoxins or staphylococcal enterotoxins A and C (SEA and SEC, respectively) from samples taken from different purification steps. The most efficient procedure in endotoxin removal was the combination of ultrafiltration and EndoTrap HD affinity column, which was able to reduce the endotoxin-to-phage ratio of vB_EcoM_fHoEco02 lysate from 3.5 × 10(4) Endotoxin Units (EU)/10(9) plaque forming units (PFU) to 0.09 EU/10(9) PFU. The combination of ultrafiltration and anion exchange chromatography resulted in ratio 96 EU/10(9) PFU, and the addition of octanol extraction step into this procedure still reduced this ratio threefold. The other methods tested either resulted to less efficient endotoxin removal or required the use of harmful chemicals that should be avoided when producing phage preparations for medical use. Ultrafiltration with 100,000 MWCO efficiently removed enterotoxins from vB_SauM_fRuSau02 lysate (from 1.3 to 0.06 ng SEA/10(9) PFU), and anion exchange chromatography reduced the enterotoxin concentration below 0.25 ng/ml, the detection limit of the assay. Frontiers Media S.A. 2019-07-23 /pmc/articles/PMC6664067/ /pubmed/31396188 http://dx.doi.org/10.3389/fmicb.2019.01674 Text en Copyright © 2019 Hietala, Horsma-Heikkinen, Carron, Skurnik and Kiljunen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Hietala, Ville
Horsma-Heikkinen, Jenni
Carron, Annelie
Skurnik, Mikael
Kiljunen, Saija
The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title_full The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title_fullStr The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title_full_unstemmed The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title_short The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
title_sort removal of endo- and enterotoxins from bacteriophage preparations
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664067/
https://www.ncbi.nlm.nih.gov/pubmed/31396188
http://dx.doi.org/10.3389/fmicb.2019.01674
work_keys_str_mv AT hietalaville theremovalofendoandenterotoxinsfrombacteriophagepreparations
AT horsmaheikkinenjenni theremovalofendoandenterotoxinsfrombacteriophagepreparations
AT carronannelie theremovalofendoandenterotoxinsfrombacteriophagepreparations
AT skurnikmikael theremovalofendoandenterotoxinsfrombacteriophagepreparations
AT kiljunensaija theremovalofendoandenterotoxinsfrombacteriophagepreparations
AT hietalaville removalofendoandenterotoxinsfrombacteriophagepreparations
AT horsmaheikkinenjenni removalofendoandenterotoxinsfrombacteriophagepreparations
AT carronannelie removalofendoandenterotoxinsfrombacteriophagepreparations
AT skurnikmikael removalofendoandenterotoxinsfrombacteriophagepreparations
AT kiljunensaija removalofendoandenterotoxinsfrombacteriophagepreparations